ARQT - Arcutis Biotherapeutics, Inc.
IEX Last Trade
14.88
-0.100 -0.672%
Share volume: 55,897
Last Updated: Thu 26 Dec 2024 08:30:16 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$14.98
-0.10
-0.67%
Summary score
25%
Profitability
25%
Dept financing
16%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-35.95%
Return on assets
-15.54%
Return on sales
-3057.21%
Return on invested capital
280.07%
Total debt ratio
36.76%
Debt ratio change over timeo
-0.81%
Current Ratio
13.57%
Quick Ratio
13.58%
Cash Position Ratio
12.6%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-68.62%
Return on assets
-14.49%
Return on sales
-474.81%
Return on invested capital
178.56%
Total debt ratio
71.49%
Debt ratio change over timeo
-0.51%
Current Ratio
8.03%
Quick Ratio
7.74%
Cash Position Ratio
6.78%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-15.73%
Return on assets
-6.61%
Return on sales
-63.79%
Return on invested capital
96.07%
Total debt ratio
52.99%
Debt ratio change over time
-0.71%
Current Ratio
9.89%
Quick Ratio
9.61%
Cash Position Ratio
8.54%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-118.45%
Return on assets
-106.67%
Return on sales
-1249.11%
Return on invested capital
6.61%
Total debt ratio
-81.27%
Debt ratio change over time
-0.81%
Current Ratio
3.93%
Quick Ratio
3.86%
Cash Position Ratio
3.5%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ARQT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -35.95% | 13.79% | 34.47% | 7.43% |
| Return on assets | -15.54% | 2.76% | 3.15% | 5.62% |
| Return on sales | -3057.21% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 280.07% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 57% |
| Total debt ratio | 36.76% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.81% | 308.97% | -6.99% | 1.18% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 8.03% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 7.74% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.78% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 8% | 19% |
| Short-term ratios | ARQT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -68.62% | 13.77% | 13.25% | 3.8% |
| Return on assets | -14.49% | 2.43% | 1.89% | 3.09% |
| Return on sales | -474.81% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 178.56% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 71.49% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.51% | 46.38% | -72.08% | 1.51% |
| Dept financing | 19% | 50% | 25% | 7% |
| Current Ratio | 8.03% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 7.74% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6.78% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 17% | 43% |